Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Specialty API Synthesis Technologies Attract Attention

Oct 6, 2014

While advances in chemocatalysis for chiral synthesis continue apace, many companies have focused attention on the development of a wider array of enzymes that can be used under commercial manufacturing conditions for the selective conversion of various substrates into more complex intermediates.

New Technologies Enhance the Formulation of Highly Potent Drugs

Advances in solid and liquid formulation techniques are providing more options.
Oct 2, 2014

Advances in solid and liquid formulation techniques are providing more options.

Fluorination Remains Key Challenge in API Synthesis

Safer fluorinating reagents and access to GMP fluorination capabilities remain challenges in API synthesis.
Oct 2, 2014

Safer fluorinating reagents and access to GMP fluorination capabilities remain challenges in API synthesis.

QbD Facilitates Robust API Development

With a quality-by-design approach, robust processes can help deliver quality product consistently.
Sep 29, 2014

With a quality-by-design approach, robust processes can help deliver quality product consistently.

Pharma Outsourcing Driving Need for Cloud-Based Services

Sep 29, 2014

Multidirectional collaboration is critical for the new pharma business model; cloud-based information services can offer a communications alternative.

New Techniques Advance Asymmetric Synthesis

A literature survey underscores the breadth of chiral chemocatalysis and interesting new techniques for the selective preparation of asymmetric compounds.
Sep 29, 2014

A literature survey underscores the breadth of chiral chemocatalysis and interesting new techniques for the selective preparation of asymmetric compounds.

QbD in API Manufacturing

With a quality-by-design approach, robust processes consistently can help deliver quality product.
Sep 2, 2014

With a quality-by-design approach, robust processes consistently can help deliver quality product.

Asymmetric Synthesis Continues to Advance

A survey of the recent literature reveals numerous advances in asymmetric chemocatalysis.
Sep 2, 2014

A survey of the recent literature reveals numerous advances in asymmetric chemocatalysis.

Taking Action on Elemental Impurities

Changing regulations are impacting the identification and monitoring of variable materials in excipients.
Sep 1, 2014

Changing regulations are impacting the identification and monitoring of variable materials in excipients.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here